Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study

被引:0
|
作者
Peng Yang
Xiao Zhou
Xuefeng Yang
Yuefeng Wang
Tao Sun
Shiying Feng
Xianyou Ma
机构
[1] Daqing Oilfield General Hospital,Department of Cardiothoracic Surgery
[2] Daqing Oilfield General Hospital,Department of Oncology
关键词
Camrelizumab; Chemotherapy; Neoadjuvant therapy; Esophageal squamous cell carcinoma; Efficacy and safety;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?
    Jiacong Liu
    Linhai Zhu
    Xuhua Huang
    Zhongjie Lu
    Yanye Wang
    Yuhong Yang
    Jiayue Ye
    Chen Gu
    Wang Lv
    Chong Zhang
    Jian Hu
    Journal of Cancer Research and Clinical Oncology, 150
  • [32] Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy
    Xu, Liwei
    Qi, Yajun
    Jiang, Youhua
    Ji, Yongling
    Zhao, Qiang
    Wu, Jie
    Lu, Weishan
    Wang, Yinjie
    Chen, Qixun
    Wang, Changchun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (06)
  • [33] Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial
    Gong, Lei
    Yang, Yueyang
    Zhang, Hongdian
    Qiao, Yufeng
    Wang, Haitong
    Ren, Peng
    Tang, Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
    Liu, Jun
    Yang, Yang
    Liu, Zhichao
    Fu, Xiaolong
    Cai, Xiaoyue
    Li, Hongxuan
    Zhu, Li
    Shen, Yan
    Zhang, Hong
    Sun, Yifeng
    Chen, Hezhong
    Yu, Bentong
    Zhang, Renquan
    Shao, Jinchen
    Zhang, Ming
    Li, Zhigang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [35] A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).
    Li, Zhao
    Xu, Peng-Fei
    Mao, Wei-Min
    Kuang, YuKang
    Fan, Hai-Yin
    Zou, Bin
    Zhu, Jian-Feng
    Li, Chao
    Cheng, Xiao-Liang
    Liu, Xing-Fei
    Guo, Changying
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16038 - E16038
  • [36] Camrelizumab combined with apatinib as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A phase 2 trial
    Meng, Xiangrui
    Qi, Yu
    Shan, Zhengzheng
    Yang, Yang
    Fan, Qingxia
    Wang, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC).
    Lv, Huilai
    Tian, Yang
    Huang, Chao
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes
    Ma, Xiao
    Zhao, Weixin
    Li, Bin
    Yu, Yongfu
    Ma, Yuan
    Thomas, Mathew
    Zhang, Yawei
    Xiang, Jiaqing
    Zhang, Yiliang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Yang, Guozhen
    Su, Xiaodong
    Yang, Hong
    Luo, Guangyu
    Gao, Chan
    Zheng, Yating
    Xie, Wenzhuan
    Huang, Mengli
    Bai, Yuezong
    Wang, Zhiqiang
    Cai, Peiqiang
    He, Haoqiang
    Xiang, Jin
    Cai, Muyuan
    Zhang, Yijun
    Qu, Chunhua
    Fu, Jianhua
    Liu, Qianwen
    Hu, Yi
    Zhong, Jiudi
    Huang, Yuanheng
    Guo, Qiyu
    Zhang, Xu
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Zhang, Xu
    Yang, Guozhen
    Su, Xiaodong
    Luo, Guangyu
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Gao, Chan
    Huang, Mengli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)